CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients
about
An overview of epigenetics and chemopreventionInfluence of cysteine 164 on active site structure in rat cysteine dioxygenaseLong term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylationCysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers.Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesisGene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.Epigenetics markers of metastasis and HPV-induced tumorigenesis in penile cancerMethylated APC and RASSF1A in multiple specimens contribute to the differential diagnosis of patients with undetermined solitary pulmonary nodules.Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast CancerGenome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival OutcomeDifferential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer.Aberrant promoter CpG methylation and its translational applications in breast cancer.Epigenetic research in cancer epidemiology: trends, opportunities, and challengesFrequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines.Do anthracyclines still have a role in adjuvant chemotherapy of breast cancer?Novel target genes and a valid biomarker panel identified for cholangiocarcinomaThe epigenetic landscape of renal cancer.Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth.Understanding human thiol dioxygenase enzymes: structure to function, and biology to pathology.CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients.Genome-wide analysis of DNA methylation and their associations with long noncoding RNA/mRNA expression in non-small-cell lung cancer.Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.Promoter DNA methylation of CDO1 gene and its clinical significance in esophageal squamous cell carcinoma.
P2860
Q24623823-19CD7EEB-2882-4BFE-85AE-262923C53D5CQ27704893-971377B4-EE01-4C4A-B71A-3FE2ABD7771FQ28476454-288160F1-3D3B-4D06-AA9F-0795CAF30890Q31101539-D23FCBF9-FD16-434A-994C-CBB787C480BCQ33739319-A65F74D8-5ED8-450B-8ED3-6E9981C23221Q35078001-2506F052-73B6-4FE1-B90B-9C45527EE886Q35154365-2EDEE647-11A3-481F-91D6-6B84EEB0BDB7Q35290472-2E6B234D-968F-478A-9FD9-CA501E792A09Q35898006-B00DD5A6-FCB7-4394-9C1E-F988589C95CEQ36093867-10DC5644-CD28-4B20-A375-412D88631616Q36182156-C1A13547-8CE4-456F-A62B-557485133F3FQ36706060-A1C43289-43CD-423A-B9EF-2B7420073C3AQ37354053-D9A91EFA-6CA2-4EF9-8D30-828F1AFB62E4Q37587537-2C3F56D7-38A9-41C3-A5A8-948951BACD6CQ37700875-EF4482AE-5B78-43B7-A7AD-F801C2A8B46CQ37822734-EBA5F88D-6DB2-4DEC-8947-28727ABDA544Q38321676-6C9B7B12-CE08-47E0-BA47-6824B4CC4F83Q39021700-34C9A277-3F6F-473B-86FE-9F22CF075820Q39042132-921CD03B-5BF5-472C-A290-6E149A1FDA55Q39260601-D78AA5E7-3EA3-4018-9072-0FEE97D3CCA5Q39334962-8053061F-48EF-41CF-9CFA-BBD248D76189Q40368914-3810685B-5E54-407E-8C7F-ADA24D914B81Q47094445-9C410EBE-472F-47D1-9262-AF8FA425C7E5Q54144077-4D50D4CC-34CB-4276-9CA0-CE90C28D6BC2
P2860
CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CDO1 promoter methylation is a ...... ositive breast cancer patients
@ast
CDO1 promoter methylation is a ...... ositive breast cancer patients
@en
type
label
CDO1 promoter methylation is a ...... ositive breast cancer patients
@ast
CDO1 promoter methylation is a ...... ositive breast cancer patients
@en
prefLabel
CDO1 promoter methylation is a ...... ositive breast cancer patients
@ast
CDO1 promoter methylation is a ...... ositive breast cancer patients
@en
P2093
P2860
P356
P1433
P1476
CDO1 promoter methylation is a ...... ositive breast cancer patients
@en
P2093
Anne Fassbender
Dimo Dietrich
Frédérique Spyratos
John A Foekens
John W M Martens
Jörn Dietrich
Jörn Lewin
Manfred Schmitt
Manuel Krispin
Ralf Lesche
P2860
P2888
P356
10.1186/1471-2407-10-247
P407
P577
2010-06-01T00:00:00Z
P5875
P6179
1016786785